Argonautica Private Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.69M Sell
2,926
-73
-2% -$74K 0.81% 39
2025
Q4
$3.22M Sell
2,999
-53
-2% -$50.7K 0.95% 32
2025
Q3
$2.33M Sell
3,052
-43
-1% -$32K 0.68% 45
2025
Q2
$2.41M Sell
3,095
-113
-4% -$87.8K 0.76% 42
2025
Q1
$2.65M Buy
3,208
+16
+0.5% +$13.3K 0.91% 35
2024
Q4
$2.46M Buy
3,192
+13
+0.4% +$10.8K 0.8% 39
2024
Q3
$2.82M Buy
3,179
+49
+2% +$44.1K 0.93% 29
2024
Q2
$2.83M Buy
3,130
+361
+13% +$289K 0.97% 27
2024
Q1
$2.15M Buy
+2,769
New +$1.97M 0.77% 41

Other funds holding LLY

Argonautica Private Wealth Management's LLY Position: Q1 2026 in Review

Argonautica Private Wealth Management reduced its Eli Lilly (LLY) stake by 2.4% in Q1 2026, selling an estimated $74K and leaving 2,926 shares worth $2.69M. The position accounts for 0.81% of the portfolio, ranked #39.

Argonautica Private Wealth Management first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. The position peaked at $3.22M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Argonautica Private Wealth Management held 2,926 shares of Eli Lilly worth $2.69M as of Q1 2026.
  • Argonautica Private Wealth Management sold 73 Eli Lilly shares in Q1 2026, an estimated $74K.
  • Eli Lilly made up 0.81% of Argonautica Private Wealth Management's portfolio in Q1 2026, its #39 holding.
  • Argonautica Private Wealth Management first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
  • Argonautica Private Wealth Management's Eli Lilly position peaked at $3.22M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Argonautica Private Wealth Management's 13F filing for Q1 2026, filed 28 Apr 2026.